Stereotactic radiotherapy for stage I non-small-cell lung cancer - the triumph of technology over biology?

被引：8
|
作者：
Ball, David
Withers, H. Rodney
机构：
[1] Peter MacCallum Canc Ctr, Div Radiat Oncol, Melbourne, Vic 3002, Australia
[2] Peter MacCallum Canc Ctr, Lung Serv, Melbourne, Vic 3002, Australia
[3] Univ Melbourne, Melbourne, Vic, Australia
[4] Univ Calif Los Angeles, Los Angeles, CA USA
来源：
NATURE CLINICAL PRACTICE ONCOLOGY | 2007年 / 4卷 / 11期
关键词：
D O I：
10.1038/ncponc0954
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：614 / 615
页数：2
相关论文
共 50 条
  • [31] Feasible Optimization of Stereotactic Ablative Radiotherapy Dose by Tumor Size for Stage I Non-small-cell Lung Cancer
    Lee, Sumin
    Song, Si Yeol
    Kim, Su Ssan
    Choi, Wonsik
    Je, Hyoung Uk
    Back, Geum Mun
    Cho, Byungchul
    Jeong, Seong-Yun
    Choi, Eun Kyung
    CLINICAL LUNG CANCER, 2018, 19 (02) : E253 - E261
  • [32] Stereotactic Body Radiotherapy Using a Radiobiology-Based Regimen for Stage I Non-Small-Cell Lung Cancer
    Shibamoto, Yuta
    Hashizume, Chisa
    Baba, Fumiya
    Ayakawa, Shiho
    Miyakawa, Akifumi
    Murai, Taro
    Takaoka, Taiki
    Hattori, Yukiko
    Asai, Ryuji
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (06) : 960 - 964
  • [33] Outcomes of accelerated hypofractionated radiotherapy in stage I non-small-cell lung cancer
    Yung, T.
    Giuliani, M. E.
    Le, L. W.
    Sun, A.
    Cho, B. C. J.
    Bezjak, A.
    Brade, A.
    Hope, A. J.
    CURRENT ONCOLOGY, 2012, 19 (04) : E264 - E269
  • [34] STEREOTACTIC BODY RADIOTHERAPY FOR EARLY-STAGE NON-SMALL-CELL LUNG CANCER: REPORT OF THE ASTRO EMERGING TECHNOLOGY COMMITTEE
    Buyyounouski, Mark K.
    Balter, Peter
    Lewis, Brett
    D'Ambrosio, David J.
    Dilling, Thomas J.
    Miller, Robert C.
    Schefter, Tracey
    Tome, Wolfgang
    Harris, Eleanor E. R.
    Price, Robert A., Jr.
    Konski, Andre A.
    Wallner, Paul E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (01): : 3 - 10
  • [35] Approach and assessment of automated stereotactic radiotherapy planning for early stage non-small-cell lung cancer
    Xue Bai
    Guoping Shan
    Ming Chen
    Binbing Wang
    BioMedical Engineering OnLine, 18
  • [36] Stereotactic Body Radiotherapy Versus Surgery for Early-Stage Non-Small-Cell Lung Cancer
    Li, Hui
    Shen, Yefeng
    Wu, Yuanzhou
    Cai, Shaoru
    Zhu, Yaru
    Chen, Siping
    Chen, Xin
    Chen, Qunqing
    JOURNAL OF SURGICAL RESEARCH, 2019, 243 : 346 - 353
  • [37] Approach and assessment of automated stereotactic radiotherapy planning for early stage non-small-cell lung cancer
    Bai, Xue
    Shan, Guoping
    Chen, Ming
    Wang, Binbing
    BIOMEDICAL ENGINEERING ONLINE, 2019, 18 (01)
  • [38] Nodal recurrences after stereotactic body radiotherapy for early stage non-small-cell lung cancer
    Tibdewal, Anil
    Pathak, Rima S.
    Agarwal, Jai Prakash
    Hoskote, Sumedh S.
    Mummudi, Naveen
    Iyer, Veena
    Nair, Akshay G.
    CURRENT PROBLEMS IN CANCER, 2021, 45 (02)
  • [39] Stereotactic Body Radiotherapy (SBRT) with Lower Doses for Selected Patients with Stage I Non-small-cell Lung Cancer (NSCLC)
    Janssen, Stefan
    Kaesmann, Lukas
    Rudat, Volker
    Rades, Dirk
    LUNG, 2016, 194 (02) : 291 - 294
  • [40] QUANTIFYING PULMONARY FUNCTION CHANGES AFTER STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR) FOR STAGE I NON-SMALL-CELL LUNG CANCER
    Phernambucq, Erik C.
    Lagerwaard, Frank J.
    Van De Ven, Peter M.
    Groepenhoff, Herman
    Postmus, Pieter E.
    Slotman, Ben
    Smit, Egbert F.
    Senan, Suresh
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S385 - S386
12345